Atricure Inc (NASDAQ: ATRC) is 41.16% higher on its value in year-to-date trading and has touched a low of $20.20 and a high of $43.11 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ATRC stock was last observed hovering at around $31.39 in the last trading session, with the day’s gains setting it 0.37%.
Currently trading at $31.76, the stock is -2.65% and -2.38% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.17 million and changing 1.18% at the moment leaves the stock -5.32% off its SMA200. ATRC registered 3.93% gain for a year compared to 6-month gain of 4.99%. The firm has a 50-day simple moving average (SMA 50) of $32.533 and a 200-day simple moving average (SMA200) of $33.5435.
The stock witnessed a -8.55% loss in the last 1 month and extending the period to 3 months gives it a -6.94%, and is -3.41% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.08% over the week and 3.20% over the month.
Atricure Inc (ATRC) has around 1300 employees, a market worth around $1.57B and $480.08M in sales. Profit margin for the company is -7.95%. Distance from 52-week low is 57.23% and -26.33% from its 52-week high. The company has generated returns on investments over the last 12 months (-7.21%).
The EPS is expected to grow by 41.74% this year
322.0 institutions hold shares in Atricure Inc (ATRC), with institutional investors hold 107.21% of the company’s shares. The shares outstanding are 49.49M, and float is at 47.71M with Short Float at 3.27%. Institutions hold 103.60% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 4.62 million shares valued at $105.24 million. The investor’s holdings represent 9.853 of the ATRC Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 4.62 million shares valued at $105.1 million to account for 9.8399 of the shares outstanding. The other top investors are ALLIANCEBERNSTEIN L.P. which holds 4.2 million shares representing 8.9641 and valued at over $95.75 million, while CHAMPLAIN INVESTMENT PARTNERS, LLC holds 5.7024 of the shares totaling 2.67 million with a market value of $60.91 million.
Atricure Inc (ATRC) Insider Activity
The most recent transaction is an insider sale by Doraiswamy Vinayak, the company’s Chief Scientific Officer. SEC filings show that Doraiswamy Vinayak sold 2,500 shares of the company’s common stock on May 28 ’25 at a price of $33.44 per share for a total of $83600.0. Following the sale, the insider now owns 73550.0 shares.
Still, SEC filings show that on Mar 05 ’25, Prange Karen (Director) disposed off 6,100 shares at an average price of $38.12 for $0.23 million. The insider now directly holds 17,828 shares of Atricure Inc (ATRC).
